RHOA and diffuse large B-cell lymphoma: On the other hand, STAT3 supports amoeboid migration in diffuse large B-cell lymphoma (DLBCL), via ARHGEF2-RhoA signalling, whereby JAK inhibition reduces dissemination (Pan et al., 2018).